Cutaneous reactions to carbamazepine in children with epilepsy

Authors

  • Asma Zamiri Student Research Committee, School of Medicine, Golestan University of Medical Sciences, Gorgan, Iran https://orcid.org/0000-0002-8936-901X
  • Sepide Amoiyan Student Research Committee, School of Medicine, Golestan University of Medical Sciences, Gorgan, Iran
  • Sina Mostafavi-Toroghi Student Research Committee, School of Medicine, Golestan University of Medical Sciences, Gorgan, Iran
  • Mahdi Babaei-Hatkehlouei Student Research Committee, Mazandaran University of Medical Sciences, Sari, Iran
  • Amirhossein Moaddabi Department of Oral and Maxillofacial Surgery, School of Dentistry, Mazandaran University of Medical Sciences, Sari, Iran
  • Mehran Ebrahimzadeh-Hassanabadi Student Research Committee, Mazandaran University of Medical Sciences, Sari, Iran
  • Tahereh Bakhshi Student Research Committee, School of Paramedicine, Golestan University of Medical Sciences, Gorgan, Iran https://orcid.org/0000-0003-4929-8760

DOI:

https://doi.org/10.22122/cdj.v7i4.412

Keywords:

Carbamazepine, Epilepsy, Cutaneous Adverse Drug Reactions, Antiepileptic Drugs

Abstract

BACKGROUND: The main components in controlling and treating seizures are antiepileptic drugs (AEDs). Mostly, the systemic side effects of these drugs are regarded very important; however, these drugs can also cause serious mucocutaneous side effects. Carbamazepine is a drug which is used to treat epilepsy. Side effects of this drug can range from skin rash to toxic epidermal necrolysis (TEN) and Stevens-Johnson syndrome (SJS). The purpose of this study was to evaluate skin complications of carbamazepine in children with epilepsy.

METHODS: This study was performed on 99 children, aged 2 months to 11 years, with the diagnosis of skin complications after taking carbamazepine. Records were examined and their initial profiles including their medical skin conditions and rashes were recorded within the checklist. Data were entered into SPSS software. Measures of central tendency and dispersion were achieved. Finally, the relationship between the drug and the cutaneous reactions of these patients was analyzed using the chi-square test.

RESULTS: The most common complications among the patients were maculopapular lesions and skin erythroderma, with the prevalence of 37.4% for each. Other types of skin lesions included papules with 14.1%, macules with 8.1%, and SJS with 3.0%. A significant association (P = 0.02) between the types of the skin lesion and the dose of carbamazepine was observed; the more the dosage was, the more severe skin lesions were.

CONCLUSION: The most common cutaneous reactions to carbamazepine were erythroderma and maculopapular rash in the patients. The findings of this study also revealed that the lack of drug compliance was of high importance.

References

Mustafa SS, Ostrov D, Yerly D. Severe Cutaneous Adverse Drug Reactions: Presentation, Risk Factors, and Management. Curr Allergy Asthma Rep 2018; 18(4): 26.

Perucca P, Gilliam FG. Adverse effects of antiepileptic drugs. Lancet Neurol 2012; 11(9): 792-802.

Balogou AA, Grunitzky EK, Belo M, Sankaredja M, Djagba DD, Tatagan-Agbi K, et al. Management of epilepsy patients in Batamariba district, Togo. Acta Neurol Scand 2007; 116(4): 211-6.

Mamishi S, Fattahi F, Pourpak Z, Aghaee FM, Moinfar Z, Mohammadi M, et al. Severe cutaneous reactions caused by barbiturates in seven Iranian children. Int J Dermatol 2009; 48(11): 1254-61.

Garcia JB, Ferro LS, Carvalho AB, da Rocha RM, de Souza LM. Severe carbamazepine-induced cutaneous reaction in the treatment of post-herpetic neuralgia. Case report. Rev Bras Anestesiol 2010; 60(4): 429-37.

Huang HY, Luo XQ, Chan LS, Cao ZH, Sun XF, Xu JH. Cutaneous adverse drug reactions in a hospital-based Chinese population. Clin Exp Dermatol 2011; 36(2): 135-41.

Albsoul-Younes A, Gharaibeh L, Murtaja AA, Masri A, Alabbadi I, Al-Qudah AA. Patterns of antiepileptic drugs use in epileptic pediatric patients in Jordan. Neurosciences (Riyadh) 2016; 21(3): 264-7.

Emich-Widera E, Likus W, Kazek B, Niemiec P, Balcerzyk A, Sieron AL, et al. CYP3A5*3 and C3435T MDR1 polymorphisms in prognostication of drug-resistant epilepsy in children and adolescents. Biomed Res Int 2013; 2013: 526837.

Yun W, Zhang F, Hu C, Luo X, Xue P, Wang J, et al. Effects of EPHX1, SCN1A and CYP3A4 genetic polymorphisms on plasma carbamazepine concentrations and pharmacoresistance in Chinese patients with epilepsy. Epilepsy Res 2013; 107(3): 231-7.

Franco V, Perucca E. The pharmacogenomics of epilepsy. Expert Rev Neurother 2015; 15(10): 1161-70.

Downloads

Published

2019-09-23

How to Cite

1.
Zamiri A, Amoiyan S, Mostafavi-Toroghi S, Babaei-Hatkehlouei M, Moaddabi A, Ebrahimzadeh-Hassanabadi M, Bakhshi T. Cutaneous reactions to carbamazepine in children with epilepsy. Chron Dis J. 2019;7(4):240–245.

Issue

Vol 7, No 4 (2019)

Section

Original Article(s)

Most read articles by the same author(s)